José‐Francisco Rocha

1.8k total citations
49 papers, 1.3k citations indexed

About

José‐Francisco Rocha is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, José‐Francisco Rocha has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Neurology, 19 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in José‐Francisco Rocha's work include Parkinson's Disease Mechanisms and Treatments (31 papers), Neurological disorders and treatments (21 papers) and Attention Deficit Hyperactivity Disorder (10 papers). José‐Francisco Rocha is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (31 papers), Neurological disorders and treatments (21 papers) and Attention Deficit Hyperactivity Disorder (10 papers). José‐Francisco Rocha collaborates with scholars based in Portugal, United Kingdom and France. José‐Francisco Rocha's co-authors include Patrício Soares‐da‐Silva, Joaquim J. Ferreira, Olivier Rascol, Andrew J. Lees, Amílcar Falcão, Teresa Nunes, Werner Poewe, Luís Almeida, Manuel Vaz‐da‐Silva and Lyndon Wright and has published in prestigious journals such as Neurology, The Lancet Neurology and CHEST Journal.

In The Last Decade

José‐Francisco Rocha

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José‐Francisco Rocha Portugal 17 680 308 286 197 190 49 1.3k
Yoshikazu Tasaki Japan 19 313 0.5× 28 0.1× 89 0.3× 491 2.5× 384 2.0× 62 1.1k
Michał Prendecki Poland 15 157 0.2× 18 0.1× 103 0.4× 118 0.6× 359 1.9× 27 937
Shrishailam Yemul United States 18 202 0.3× 27 0.1× 34 0.1× 152 0.8× 458 2.4× 28 1.2k
Carlos Fernandes‐Lopes Portugal 11 29 0.0× 367 1.2× 40 0.1× 41 0.2× 217 1.1× 24 754
Nanqu Huang China 17 88 0.1× 44 0.1× 26 0.1× 86 0.4× 401 2.1× 61 1.0k
Concetta Dagostino Italy 13 28 0.0× 43 0.1× 85 0.3× 138 0.7× 185 1.0× 19 742
Peter Nguyen United States 16 92 0.1× 10 0.0× 84 0.3× 323 1.6× 366 1.9× 36 1.3k
Manabu Suno Japan 12 175 0.3× 21 0.1× 20 0.1× 134 0.7× 158 0.8× 42 606

Countries citing papers authored by José‐Francisco Rocha

Since Specialization
Citations

This map shows the geographic impact of José‐Francisco Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José‐Francisco Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José‐Francisco Rocha more than expected).

Fields of papers citing papers by José‐Francisco Rocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José‐Francisco Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José‐Francisco Rocha. The network helps show where José‐Francisco Rocha may publish in the future.

Co-authorship network of co-authors of José‐Francisco Rocha

This figure shows the co-authorship network connecting the top 25 collaborators of José‐Francisco Rocha. A scholar is included among the top collaborators of José‐Francisco Rocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José‐Francisco Rocha. José‐Francisco Rocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Joaquim J., Miguel Gago, Raquel Costa, et al.. (2025). Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial. Journal of Parkinson s Disease. 15(1). 87–96. 1 indexed citations
2.
Ferreira, Joaquim J., Olivier Rascol, Fabrizio Stocchi, et al.. (2025). Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial. European Journal of Neurology. 32(1). e16420–e16420. 2 indexed citations
3.
Rodacki, Melanie, José‐Francisco Rocha, Isabel Rey, et al.. (2025). Increase in new-onset type 1 diabetes diagnoses among Brazilian children and adolescents during the COVID-19 pandemic. Jornal de Pediatria. 101(4). 651–656.
4.
5.
Ferreira, Joaquim J., Olivier Rascol, Fabrizio Stocchi, et al.. (2024). Opicapone as Add-on to Levodopa in Parkinson's Patients without Motor Complications: Preliminary Data from EPSILON. Parkinsonism & Related Disorders. 122. 106127–106127. 1 indexed citations
6.
Ferreira, Joaquim J., Jee‐Young Lee, Hyeo‐Il Ma, et al.. (2024). Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies. Journal of Neurology. 271(10). 6729–6738. 1 indexed citations
7.
Rocha, José‐Francisco, Georg Ebersbach, Andrew J. Lees, et al.. (2022). The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II. Frontiers in Neurology. 13. 994114–994114. 5 indexed citations
8.
Hauser, R., Mark Lew, Cynthia L. Comella, et al.. (2020). Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses. Parkinsonism & Related Disorders. 79. e53–e54. 2 indexed citations
9.
10.
Ferreira, Joaquim J., Andrew J. Lees, José‐Francisco Rocha, et al.. (2015). Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial. The Lancet Neurology. 15(2). 154–165. 184 indexed citations
11.
12.
Ferreira, Joaquim J., et al.. (2015). Pooled efficacy of opicapone as adjunctive therapy to levodopa in patients with Parkinson’s disease and motor fluctuations. Parkinsonism & Related Disorders. 22. e101–e101. 2 indexed citations
13.
Ferreira, Joaquim J., José‐Francisco Rocha, Amílcar Falcão, et al.. (2015). Effect of opicapone on levodopa pharmacokinetics, catechol‐O‐methyltransferase activity and motor fluctuations in patients with Parkinson's disease. European Journal of Neurology. 22(5). 815–815. 51 indexed citations
14.
Rocha, José‐Francisco, Amílcar Falcão, A. Santos, et al.. (2014). Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations. European Journal of Clinical Pharmacology. 70(9). 1059–1071. 49 indexed citations
15.
Ferreira, Joaquim J., Olivier Rascol, Werner Poewe, et al.. (2010). A Double‐Blind, Randomized, Placebo and Active‐Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease. CNS Neuroscience & Therapeutics. 16(6). 337–347. 18 indexed citations
16.
Rocha, José‐Francisco, Manuel Vaz‐da‐Silva, Luís Almeida, et al.. (2009). Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 47(4). 255–261. 16 indexed citations
17.
Nunes, Teresa, Luís Almeida, José‐Francisco Rocha, et al.. (2009). Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects. The Journal of Clinical Pharmacology. 49(12). 1477–1482. 89 indexed citations
18.
Almeida, Luís, Manuel Vaz‐da‐Silva, Amílcar Falcão, et al.. (2009). Pharmacokinetic and safety profile oftrans‐resveratrol in a rising multiple‐dose study in healthy volunteers. Molecular Nutrition & Food Research. 53(S1). S7–15. 369 indexed citations
19.
Ribeiro, Carlos, Tice Macedo, Teresa Nunes, et al.. (2008). Dosage Form Proportionality and Food Effect of the Final Tablet Formulation of Eslicarbazepine Acetate. Drugs in R&D. 9(6). 447–454. 16 indexed citations
20.
Almeida, Luís, Amílcar Falcão, Manuel Vaz‐da‐Silva, et al.. (2008). Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. European Journal of Clinical Pharmacology. 64(10). 961–966. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshikazu Tasaki Breakdown of academic impact, for papers by Michał Prendecki Breakdown of academic impact, for papers by Shrishailam Yemul Breakdown of academic impact, for papers by Carlos Fernandes‐Lopes Breakdown of academic impact, for papers by Nanqu Huang Breakdown of academic impact, for papers by Concetta Dagostino Breakdown of academic impact, for papers by Peter Nguyen Breakdown of academic impact, for papers by Manabu Suno
Rankless by CCL
2026